Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Will

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 6, 1999
Paget's disease: acquired resistance to one aminobisphosphonate with retained response to anotherD H Gutteridge, L C Ward, G O Stewart, et al.
Bone|March 31, 2004
A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of boneJ P Walsh, L C Ward, G O Stewart, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 9, 2000
Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbersM L Holzherr, R W Retallack, D H Gutteridge, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)U Budde, R Schneppenheim, J Eikenboom, et al.
Calcified Tissue International|September 26, 2003
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip densityD H Gutteridge, M L Holzherr, R W Retallack, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD studyJ Eikenboom, L Hilbert, A S Ribba, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 6, 1999
Paget's disease: acquired resistance to one aminobisphosphonate with retained response to anotherD H Gutteridge, L C Ward, G O Stewart, et al.
Bone|March 31, 2004
A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of boneJ P Walsh, L C Ward, G O Stewart, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 9, 2000
Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbersM L Holzherr, R W Retallack, D H Gutteridge, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)U Budde, R Schneppenheim, J Eikenboom, et al.
Calcified Tissue International|September 26, 2003
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip densityD H Gutteridge, M L Holzherr, R W Retallack, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD studyJ Eikenboom, L Hilbert, A S Ribba, et al.
Pageof 5